Afterload mismatch after transcatheter edge‐to‐edge repair in functional mitral regurgitation: A propensity‐score matched analysis
- 27 March 2025
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 55 (8) , e70040
Abstract
Background: Transcatheter edge‐to‐edge repair (TEER) for severe functional mitral regurgitation (FMR) in patients with reduced left ventricular ejection fraction (LVEF) may lead to an acute increase in left ventricular afterload, termed afterload mismatch (AM). This study aimed to redefine AM clinically, analyse its determinants, and assess its prognostic impact post‐TEER in FMR patients.Methods: A multicenter case–control study was conducted, involving FMR patients with LVEF ≤35% undergoing TEER. AM post‐TEER was defined as the acute (within 24 h) need for escalation of inotropic or mechanical circulatory support. Sixty‐eight AM cases were compared with 68 propensity‐matched patients. Primary endpoints included in‐hospital mortality post‐TEER and 2‐year all‐cause mortality.Results: Median age was 68 years, 76% male. Procedural success was achieved in 92% of patients. Proportionate MR was associated with a higher risk of AM (adj‐HR 1.6, 95% CI 1.01–2.6, p = .04). Conversely, pretreatment with levosimendan (adj‐HR .29, 95% CI .12–.70, p < .01) and higher furosemide dose (adj‐HR per furosemide 10 mg increase .86, 95% CI .76–.98, p = .03) were protective. In‐hospital mortality was higher in the AM cohort (10% vs. 2%, p = .03), while 2‐year mortality rates were similar (34% vs. 20%, p = .09). Multivariable analysis revealed higher AM grades and post‐procedural MR as predictors of in‐hospital mortality and lack of procedural success for 2‐year mortality.Conclusions: Among patients with LVEF ≤35% and severe FMR undergoing TEER, AM was associated with in‐hospital mortality but did not impact long‐term outcomes. Proportionate MR increased the risk of AM, while pretreatment with levosimendan and higher furosemide doses was protective.Keywords
This publication has 24 references indexed in Scilit:
- A Score to Assess Mortality After Percutaneous Mitral Valve RepairJACC, 2022
- New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral RegurgitationJAMA Cardiology, 2020
- Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registryAmerican Heart Journal, 2019
- Vasoactive-inotropic score and the prediction of morbidity and mortality after cardiac surgeryBritish Journal of Anaesthesia, 2019
- Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registryInternational Journal of Cardiology, 2019
- Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2018
- Recommendations for Noninvasive Evaluation of Native Valvular RegurgitationJournal of the American Society of Echocardiography, 2017
- Levosimendan as an adjunctive therapy to MitraClip implantation in patients with severe mitral regurgitation and left ventricular dysfunctionInternational Journal of Cardiology, 2016
- Afterload Mismatch After MitraClip Insertion for Functional Mitral RegurgitationThe American Journal of Cardiology, 2014
- Bases y evidencias clínicas de los efectos de los nuevos tratamientos farmacológicos en la insuficiencia cardíacaRevista Espanola de Cardiologia, 2004